Management of Myocardial Infarction and the Role of Cardiothoracic Surgery

Area of Science:

• Cardiology
• Cardiac Surgery

Background:

• Myocardial infarction (MI), primarily from coronary artery disease (CAD), is a major global cause of death.
• MI presents as ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI), each with unique causes and treatments.
• Restoring myocardial blood flow is the primary therapeutic goal for all MI types.

Purpose of the Study:

• To comprehensively review the role of cardiac surgery in managing myocardial infarction (MI).
• To identify specific scenarios where cardiac surgery is beneficial or not indicated in MI treatment.
• To analyze the interplay between percutaneous coronary intervention (PCI) and cardiac surgery in complex MI cases.

Main Methods:

• Review of current literature on MI management strategies.
• Analysis of treatment pathways for STEMI and NSTEMI.
• Evaluation of the Heart Team approach in decision-making for reperfusion therapy.

Main Results:

• STEMI typically requires urgent reperfusion therapy, often percutaneous coronary intervention (PCI).
• NSTEMI management is risk-stratified, involving medical management, PCI, or coronary artery bypass grafting (CABG).
• Cardiac surgery is crucial for complex CAD or MI-related complications like cardiogenic shock or heart failure, complementing PCI.

Conclusions:

• While PCI is a primary MI treatment, cardiac surgery remains vital for specific complex cases and complications.
• The Heart Team approach optimizes treatment selection for complex MI patients.
• Understanding the indications for cardiac surgery in MI is essential for improving patient outcomes.